

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | sodium ion export (GO:0071436) | 5.08976708 |
| 2 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 4.26272357 |
| 3 | locomotory exploration behavior (GO:0035641) | 3.97708990 |
| 4 | regulation of ARF protein signal transduction (GO:0032012) | 3.97673339 |
| 5 | synaptic vesicle maturation (GO:0016188) | 3.74783273 |
| 6 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.73367726 |
| 7 | regulation of NFAT protein import into nucleus (GO:0051532) | 3.69607573 |
| 8 | apoptotic process involved in morphogenesis (GO:0060561) | 3.69579984 |
| 9 | positive regulation of histone deacetylation (GO:0031065) | 3.63982930 |
| 10 | activation of Rac GTPase activity (GO:0032863) | 3.56740358 |
| 11 | regulation of cholesterol homeostasis (GO:2000188) | 3.54672281 |
| 12 | pre-miRNA processing (GO:0031054) | 3.51847432 |
| 13 | cellular potassium ion homeostasis (GO:0030007) | 3.48180441 |
| 14 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.42939067 |
| 15 | regulation of clathrin-mediated endocytosis (GO:2000369) | 3.29605337 |
| 16 | regulation of ARF GTPase activity (GO:0032312) | 3.29603373 |
| 17 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 3.27383009 |
| 18 | positive regulation of synapse maturation (GO:0090129) | 3.24007454 |
| 19 | negative regulation of cell size (GO:0045792) | 3.20995645 |
| 20 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.19310784 |
| 21 | NIK/NF-kappaB signaling (GO:0038061) | 3.16344940 |
| 22 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.06978609 |
| 23 | layer formation in cerebral cortex (GO:0021819) | 3.06415189 |
| 24 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.03000520 |
| 25 | negative regulation of viral release from host cell (GO:1902187) | 3.01308717 |
| 26 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 3.01115262 |
| 27 | response to peptidoglycan (GO:0032494) | 3.00129749 |
| 28 | establishment of nucleus localization (GO:0040023) | 2.97551891 |
| 29 | regulation of histone H3-K27 methylation (GO:0061085) | 2.97266655 |
| 30 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.95734360 |
| 31 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.94297841 |
| 32 | regulation of translational termination (GO:0006449) | 2.93397665 |
| 33 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.93268970 |
| 34 | response to laminar fluid shear stress (GO:0034616) | 2.90829812 |
| 35 | peptidyl-lysine dimethylation (GO:0018027) | 2.88378129 |
| 36 | regulation of extracellular matrix disassembly (GO:0010715) | 2.85772436 |
| 37 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.84957210 |
| 38 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.84032504 |
| 39 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.82843469 |
| 40 | response to pheromone (GO:0019236) | 2.82373783 |
| 41 | mannose metabolic process (GO:0006013) | 2.82036292 |
| 42 | positive regulation by symbiont of host defense response (GO:0052509) | 2.81894371 |
| 43 | modulation by symbiont of host defense response (GO:0052031) | 2.81894371 |
| 44 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.81894371 |
| 45 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.81894371 |
| 46 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.81894371 |
| 47 | modulation by symbiont of host immune response (GO:0052553) | 2.81894371 |
| 48 | negative regulation of fatty acid transport (GO:2000192) | 2.81789336 |
| 49 | T cell selection (GO:0045058) | 2.81715904 |
| 50 | negative regulation of myotube differentiation (GO:0010832) | 2.79874331 |
| 51 | regulation of early endosome to late endosome transport (GO:2000641) | 2.79376499 |
| 52 | embryonic process involved in female pregnancy (GO:0060136) | 2.78040681 |
| 53 | protein localization to endosome (GO:0036010) | 2.78031614 |
| 54 | neuromuscular process controlling balance (GO:0050885) | 2.77973289 |
| 55 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.77886337 |
| 56 | response to muramyl dipeptide (GO:0032495) | 2.77701797 |
| 57 | activation of MAPKKK activity (GO:0000185) | 2.77501444 |
| 58 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.76153717 |
| 59 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.74984452 |
| 60 | modulation by symbiont of host cellular process (GO:0044068) | 2.72578002 |
| 61 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.72169902 |
| 62 | modulation by virus of host process (GO:0019054) | 2.70559719 |
| 63 | regulation of necroptotic process (GO:0060544) | 2.65663489 |
| 64 | glucocorticoid receptor signaling pathway (GO:0042921) | 2.64816579 |
| 65 | adherens junction assembly (GO:0034333) | 2.64293195 |
| 66 | proline biosynthetic process (GO:0006561) | 2.63177464 |
| 67 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.63118054 |
| 68 | apoptotic cell clearance (GO:0043277) | 2.62866337 |
| 69 | regulation of integrin activation (GO:0033623) | 2.62362106 |
| 70 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.62263365 |
| 71 | semaphorin-plexin signaling pathway (GO:0071526) | 2.62028611 |
| 72 | pinocytosis (GO:0006907) | 2.61235845 |
| 73 | regulation of gamma-delta T cell activation (GO:0046643) | 2.59705090 |
| 74 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.58871756 |
| 75 | cell communication by electrical coupling (GO:0010644) | 2.56887990 |
| 76 | negative regulation of nucleotide catabolic process (GO:0030812) | 2.56692468 |
| 77 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.55668926 |
| 78 | cell-substrate junction assembly (GO:0007044) | 2.54840880 |
| 79 | cerebellar Purkinje cell layer development (GO:0021680) | 2.54794078 |
| 80 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.53703543 |
| 81 | activation of JUN kinase activity (GO:0007257) | 2.53347496 |
| 82 | macrophage activation involved in immune response (GO:0002281) | 2.53321940 |
| 83 | RNA stabilization (GO:0043489) | 2.53026304 |
| 84 | mRNA stabilization (GO:0048255) | 2.53026304 |
| 85 | detection of bacterium (GO:0016045) | 2.52657192 |
| 86 | megakaryocyte development (GO:0035855) | 2.51939817 |
| 87 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.51533631 |
| 88 | regulation of translational fidelity (GO:0006450) | 2.50366330 |
| 89 | regulation of necrotic cell death (GO:0010939) | 2.50100317 |
| 90 | positive regulation of fibroblast migration (GO:0010763) | 2.50092889 |
| 91 | cellular sodium ion homeostasis (GO:0006883) | 2.49961482 |
| 92 | leukocyte aggregation (GO:0070486) | 2.49180480 |
| 93 | positive regulation of nuclease activity (GO:0032075) | 2.48999707 |
| 94 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.48373129 |
| 95 | positive thymic T cell selection (GO:0045059) | 2.48149296 |
| 96 | gamma-aminobutyric acid transport (GO:0015812) | 2.47749419 |
| 97 | glucose 6-phosphate metabolic process (GO:0051156) | 2.47335795 |
| 98 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.46808525 |
| 99 | natural killer cell differentiation (GO:0001779) | 2.45546363 |
| 100 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.44814857 |
| 101 | maternal placenta development (GO:0001893) | 2.44643425 |
| 102 | mitotic G1/S transition checkpoint (GO:0044819) | 2.44332365 |
| 103 | COPI coating of Golgi vesicle (GO:0048205) | 2.43299889 |
| 104 | Golgi transport vesicle coating (GO:0048200) | 2.43299889 |
| 105 | cell-substrate adherens junction assembly (GO:0007045) | 2.42499780 |
| 106 | focal adhesion assembly (GO:0048041) | 2.42499780 |
| 107 | regulation of synapse structural plasticity (GO:0051823) | 2.42497305 |
| 108 | germinal center formation (GO:0002467) | 2.41839047 |
| 109 | potassium ion import (GO:0010107) | 2.41819843 |
| 110 | macroautophagy (GO:0016236) | 2.41769063 |
| 111 | atrioventricular valve morphogenesis (GO:0003181) | 2.40691310 |
| 112 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.40008351 |
| 113 | signal complex assembly (GO:0007172) | 2.39847641 |
| 114 | thymic T cell selection (GO:0045061) | 2.39691947 |
| 115 | pentose-phosphate shunt (GO:0006098) | 2.39490530 |
| 116 | stress fiber assembly (GO:0043149) | 2.39459923 |
| 117 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.38738416 |
| 118 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.38429755 |
| 119 | positive regulation of protein deacetylation (GO:0090312) | 2.37707328 |
| 120 | detection of other organism (GO:0098543) | 2.37241612 |
| 121 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.37110629 |
| 122 | negative thymic T cell selection (GO:0045060) | 2.36241192 |
| 123 | establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197) | 2.35621581 |
| 124 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.35167019 |
| 125 | mitotic G1 DNA damage checkpoint (GO:0031571) | 2.34816891 |
| 126 | desmosome organization (GO:0002934) | 2.34207300 |
| 127 | cellular response to epidermal growth factor stimulus (GO:0071364) | 2.33995608 |
| 128 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.33934738 |
| 129 | cellular response to virus (GO:0098586) | 2.33433564 |
| 130 | negative regulation of GTP catabolic process (GO:0033125) | 2.33431060 |
| 131 | negative regulation of GTPase activity (GO:0034260) | 2.33431060 |
| 132 | regulation of chromatin binding (GO:0035561) | 2.32897051 |
| 133 | positive regulation of gene expression, epigenetic (GO:0045815) | 2.32569393 |
| 134 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.32542894 |
| 135 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.31746564 |
| 136 | stress granule assembly (GO:0034063) | 2.31325638 |
| 137 | receptor catabolic process (GO:0032801) | 2.30761929 |
| 138 | glycine transport (GO:0015816) | 2.30138502 |
| 139 | apoptotic process involved in development (GO:1902742) | 2.29138574 |
| 140 | negative regulation of necroptotic process (GO:0060546) | 2.28271081 |
| 141 | neurotransmitter secretion (GO:0007269) | 2.28263781 |
| 142 | positive T cell selection (GO:0043368) | 2.28126573 |
| 143 | histone H3-K36 demethylation (GO:0070544) | 2.28120428 |
| 144 | negative regulation of granulocyte differentiation (GO:0030853) | 2.27872090 |
| 145 | positive regulation of receptor recycling (GO:0001921) | 2.27216575 |
| 146 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.25657819 |
| 147 | potassium ion homeostasis (GO:0055075) | 2.25624356 |
| 148 | trophectodermal cell differentiation (GO:0001829) | 2.24172999 |
| 149 | negative regulation of lipid transport (GO:0032369) | 2.23144000 |
| 150 | positive regulation of Rap GTPase activity (GO:0032854) | 2.22696769 |
| 151 | cell differentiation in hindbrain (GO:0021533) | 2.22265729 |
| 152 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.21189272 |
| 153 | negative regulation of histone methylation (GO:0031061) | 2.20694198 |
| 154 | cerebellar granule cell differentiation (GO:0021707) | 2.20084314 |
| 155 | prepulse inhibition (GO:0060134) | 2.18159167 |
| 156 | glutamate secretion (GO:0014047) | 2.17541322 |
| 157 | regulation of nuclease activity (GO:0032069) | 2.17512542 |
| 158 | activation of protein kinase A activity (GO:0034199) | 2.15691224 |
| 159 | negative regulation of purine nucleotide catabolic process (GO:0033122) | 2.15546457 |
| 160 | chromatin silencing (GO:0006342) | 2.15149831 |
| 161 | membrane tubulation (GO:0097320) | 2.14675078 |
| 162 | negative regulation of protein oligomerization (GO:0032460) | 2.13660510 |
| 163 | alanine transport (GO:0032328) | 2.12705972 |
| 164 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.11998853 |
| 165 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.11439596 |
| 166 | negative regulation of cell killing (GO:0031342) | 2.11439596 |
| 167 | regulation of polysaccharide biosynthetic process (GO:0032885) | 2.10956020 |
| 168 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.10550501 |
| 169 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.10550501 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MYC_22102868_ChIP-Seq_BL_Human | 3.44734594 |
| 2 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 3.32483097 |
| 3 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.18517927 |
| 4 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.83600152 |
| 5 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.80002315 |
| 6 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.60835302 |
| 7 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.54254219 |
| 8 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.47241963 |
| 9 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.43917411 |
| 10 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.29063642 |
| 11 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.27729684 |
| 12 | KDM2B_26808549_Chip-Seq_K562_Human | 2.24641419 |
| 13 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.17892205 |
| 14 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.15693440 |
| 15 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.14271015 |
| 16 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 2.13400147 |
| 17 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.07222711 |
| 18 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.04216496 |
| 19 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.03956628 |
| 20 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.99933647 |
| 21 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.94748448 |
| 22 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.87486291 |
| 23 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.86077645 |
| 24 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.75862114 |
| 25 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.75112045 |
| 26 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.74817976 |
| 27 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.70262364 |
| 28 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.69750781 |
| 29 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.66681611 |
| 30 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.64698143 |
| 31 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.63962376 |
| 32 | P68_20966046_ChIP-Seq_HELA_Human | 1.63794911 |
| 33 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.62161820 |
| 34 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.61589629 |
| 35 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.61111695 |
| 36 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.59289643 |
| 37 | UTX_26944678_Chip-Seq_JUKART_Human | 1.59234965 |
| 38 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.58221200 |
| 39 | MAF_26560356_Chip-Seq_TH1_Human | 1.57813236 |
| 40 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.56128853 |
| 41 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.55126224 |
| 42 | GATA1_19941826_ChIP-Seq_K562_Human | 1.54951912 |
| 43 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.54752794 |
| 44 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.53965871 |
| 45 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.53186414 |
| 46 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.52872484 |
| 47 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.51470620 |
| 48 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.47769245 |
| 49 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.46925957 |
| 50 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.44207442 |
| 51 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.43962247 |
| 52 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.42204630 |
| 53 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.41760608 |
| 54 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.41710715 |
| 55 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.41481272 |
| 56 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.39773888 |
| 57 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.39115767 |
| 58 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.38392070 |
| 59 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.36852112 |
| 60 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.35388890 |
| 61 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.35199748 |
| 62 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.34459065 |
| 63 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.33862916 |
| 64 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.32852674 |
| 65 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.32412277 |
| 66 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.31581845 |
| 67 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.31499349 |
| 68 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31266107 |
| 69 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.30828738 |
| 70 | SPI1_23127762_ChIP-Seq_K562_Human | 1.30633072 |
| 71 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.29578378 |
| 72 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.27444343 |
| 73 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.26082160 |
| 74 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.25580263 |
| 75 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.24730547 |
| 76 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.24517921 |
| 77 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.24412321 |
| 78 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.22628085 |
| 79 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.21114040 |
| 80 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.21102408 |
| 81 | ATF3_27146783_Chip-Seq_COLON_Human | 1.20928937 |
| 82 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.20413287 |
| 83 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.19807076 |
| 84 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.19611616 |
| 85 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.19019420 |
| 86 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.16256863 |
| 87 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.15460370 |
| 88 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.14629586 |
| 89 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.14346559 |
| 90 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.14224383 |
| 91 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.12740052 |
| 92 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.12422993 |
| 93 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.10634065 |
| 94 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.08602773 |
| 95 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.07774918 |
| 96 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.07419172 |
| 97 | MAF_26560356_Chip-Seq_TH2_Human | 1.07078656 |
| 98 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.06787729 |
| 99 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.06690553 |
| 100 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.06267419 |
| 101 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.05834843 |
| 102 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.05755316 |
| 103 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.05479493 |
| 104 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.05288865 |
| 105 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.05017377 |
| 106 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.04742408 |
| 107 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.03832331 |
| 108 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.02933774 |
| 109 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.02280845 |
| 110 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.01786965 |
| 111 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.01514693 |
| 112 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.01356871 |
| 113 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.99286182 |
| 114 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.99161487 |
| 115 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.99146401 |
| 116 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.98637478 |
| 117 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.98545777 |
| 118 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.98147374 |
| 119 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.97638615 |
| 120 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.97474624 |
| 121 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.96638776 |
| 122 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.96403722 |
| 123 | MYB_26560356_Chip-Seq_TH1_Human | 0.96287950 |
| 124 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 0.96024383 |
| 125 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.95820194 |
| 126 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.93932868 |
| 127 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.93869921 |
| 128 | GATA2_19941826_ChIP-Seq_K562_Human | 0.92569110 |
| 129 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.91846807 |
| 130 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.91286980 |
| 131 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.91022042 |
| 132 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.90586123 |
| 133 | FLI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.89773007 |
| 134 | GATA1_22025678_ChIP-Seq_K562_Human | 0.88909490 |
| 135 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.88454078 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 4.56820475 |
| 2 | MP0003705_abnormal_hypodermis_morpholog | 4.29887946 |
| 3 | MP0008961_abnormal_basal_metabolism | 3.47192576 |
| 4 | MP0010234_abnormal_vibrissa_follicle | 3.00138367 |
| 5 | MP0005451_abnormal_body_composition | 2.95452683 |
| 6 | MP0005076_abnormal_cell_differentiation | 2.81735375 |
| 7 | MP0003436_decreased_susceptibility_to | 2.65615162 |
| 8 | MP0003303_peritoneal_inflammation | 2.52571896 |
| 9 | MP0010352_gastrointestinal_tract_polyps | 2.43942791 |
| 10 | MP0003300_gastrointestinal_ulcer | 2.22463003 |
| 11 | MP0009840_abnormal_foam_cell | 2.16721037 |
| 12 | MP0009278_abnormal_bone_marrow | 2.15911042 |
| 13 | MP0003329_amyloid_beta_deposits | 2.13419506 |
| 14 | MP0009333_abnormal_splenocyte_physiolog | 2.11539427 |
| 15 | MP0000678_abnormal_parathyroid_gland | 2.08961845 |
| 16 | MP0008260_abnormal_autophagy | 2.07633171 |
| 17 | MP0003172_abnormal_lysosome_physiology | 2.04842529 |
| 18 | MP0003283_abnormal_digestive_organ | 1.85569154 |
| 19 | MP0004858_abnormal_nervous_system | 1.81939692 |
| 20 | MP0002877_abnormal_melanocyte_morpholog | 1.81177791 |
| 21 | MP0000569_abnormal_digit_pigmentation | 1.80935012 |
| 22 | MP0008569_lethality_at_weaning | 1.77560084 |
| 23 | MP0002909_abnormal_adrenal_gland | 1.73292738 |
| 24 | MP0000604_amyloidosis | 1.67407456 |
| 25 | MP0003635_abnormal_synaptic_transmissio | 1.67124321 |
| 26 | MP0000858_altered_metastatic_potential | 1.65739444 |
| 27 | MP0005083_abnormal_biliary_tract | 1.64525451 |
| 28 | MP0002089_abnormal_postnatal_growth/wei | 1.64039685 |
| 29 | MP0005409_darkened_coat_color | 1.63698672 |
| 30 | MP0002249_abnormal_larynx_morphology | 1.60306189 |
| 31 | MP0005360_urolithiasis | 1.58689074 |
| 32 | MP0010155_abnormal_intestine_physiology | 1.57577704 |
| 33 | MP0001835_abnormal_antigen_presentation | 1.53368516 |
| 34 | MP0000490_abnormal_crypts_of | 1.50805240 |
| 35 | MP0001849_ear_inflammation | 1.49509126 |
| 36 | MP0004947_skin_inflammation | 1.47049287 |
| 37 | MP0005025_abnormal_response_to | 1.45891345 |
| 38 | MP0004510_myositis | 1.41979702 |
| 39 | MP0005397_hematopoietic_system_phenotyp | 1.40540124 |
| 40 | MP0001545_abnormal_hematopoietic_system | 1.40540124 |
| 41 | MP0005000_abnormal_immune_tolerance | 1.39821585 |
| 42 | MP0008770_decreased_survivor_rate | 1.34511265 |
| 43 | MP0003656_abnormal_erythrocyte_physiolo | 1.34019314 |
| 44 | MP0005387_immune_system_phenotype | 1.33466691 |
| 45 | MP0001790_abnormal_immune_system | 1.33466691 |
| 46 | MP0001800_abnormal_humoral_immune | 1.33290611 |
| 47 | MP0002796_impaired_skin_barrier | 1.32391237 |
| 48 | MP0000685_abnormal_immune_system | 1.31386149 |
| 49 | MP0002419_abnormal_innate_immunity | 1.30359468 |
| 50 | MP0003252_abnormal_bile_duct | 1.29924607 |
| 51 | MP0001348_abnormal_lacrimal_gland | 1.26718112 |
| 52 | MP0003566_abnormal_cell_adhesion | 1.26134283 |
| 53 | MP0002420_abnormal_adaptive_immunity | 1.25891842 |
| 54 | MP0001819_abnormal_immune_cell | 1.25883692 |
| 55 | MP0009046_muscle_twitch | 1.24702753 |
| 56 | MP0004381_abnormal_hair_follicle | 1.21886337 |
| 57 | MP0005670_abnormal_white_adipose | 1.21165292 |
| 58 | MP0000003_abnormal_adipose_tissue | 1.20268413 |
| 59 | MP0002723_abnormal_immune_serum | 1.20033663 |
| 60 | MP0003191_abnormal_cellular_cholesterol | 1.19858428 |
| 61 | MP0003866_abnormal_defecation | 1.19672479 |
| 62 | MP0002452_abnormal_antigen_presenting | 1.17045839 |
| 63 | MP0002998_abnormal_bone_remodeling | 1.16152892 |
| 64 | MP0002396_abnormal_hematopoietic_system | 1.14724275 |
| 65 | MP0002139_abnormal_hepatobiliary_system | 1.11917051 |
| 66 | MP0005671_abnormal_response_to | 1.11599739 |
| 67 | MP0000716_abnormal_immune_system | 1.11070479 |
| 68 | MP0004233_abnormal_muscle_weight | 1.11046870 |
| 69 | MP0003045_fibrosis | 1.10298627 |
| 70 | MP0004197_abnormal_fetal_growth/weight/ | 1.09829574 |
| 71 | MP0004264_abnormal_extraembryonic_tissu | 1.09592712 |
| 72 | MP0000537_abnormal_urethra_morphology | 1.09107812 |
| 73 | MP0004185_abnormal_adipocyte_glucose | 1.08857990 |
| 74 | MP0003279_aneurysm | 1.07633965 |
| 75 | MP0005375_adipose_tissue_phenotype | 1.07462267 |
| 76 | MP0001533_abnormal_skeleton_physiology | 1.06914894 |
| 77 | MP0010329_abnormal_lipoprotein_level | 1.06818046 |
| 78 | MP0002429_abnormal_blood_cell | 1.05530965 |
| 79 | MP0002405_respiratory_system_inflammati | 1.05240493 |
| 80 | MP0004811_abnormal_neuron_physiology | 1.03696441 |
| 81 | MP0009672_abnormal_birth_weight | 1.01670460 |
| 82 | MP0003075_altered_response_to | 1.01439801 |
| 83 | MP0004808_abnormal_hematopoietic_stem | 0.99838213 |
| 84 | MP0005310_abnormal_salivary_gland | 0.97321423 |
| 85 | MP0005365_abnormal_bile_salt | 0.96966160 |
| 86 | MP0002063_abnormal_learning/memory/cond | 0.96651636 |
| 87 | MP0003115_abnormal_respiratory_system | 0.96334963 |
| 88 | MP0010307_abnormal_tumor_latency | 0.95989716 |
| 89 | MP0000371_diluted_coat_color | 0.95114808 |
| 90 | MP0000477_abnormal_intestine_morphology | 0.95106092 |
| 91 | MP0003453_abnormal_keratinocyte_physiol | 0.95090417 |
| 92 | MP0000609_abnormal_liver_physiology | 0.93901069 |
| 93 | MP0002234_abnormal_pharynx_morphology | 0.93479436 |
| 94 | MP0002064_seizures | 0.93187045 |
| 95 | MP0009931_abnormal_skin_appearance | 0.93037818 |
| 96 | MP0002086_abnormal_extraembryonic_tissu | 0.92708597 |
| 97 | MP0009780_abnormal_chondrocyte_physiolo | 0.92688146 |
| 98 | MP0000747_muscle_weakness | 0.91538599 |
| 99 | MP0003091_abnormal_cell_migration | 0.90969822 |
| 100 | MP0005501_abnormal_skin_physiology | 0.90867054 |
| 101 | MP0001730_embryonic_growth_arrest | 0.90447755 |
| 102 | MP0004885_abnormal_endolymph | 0.89745913 |
| 103 | MP0001216_abnormal_epidermal_layer | 0.89501747 |
| 104 | MP0006082_CNS_inflammation | 0.89231691 |
| 105 | MP0005621_abnormal_cell_physiology | 0.88727858 |
| 106 | MP0001666_abnormal_nutrient_absorption | 0.88552085 |
| 107 | MP0002653_abnormal_ependyma_morphology | 0.87612662 |
| 108 | MP0002060_abnormal_skin_morphology | 0.87408882 |
| 109 | MP0001845_abnormal_inflammatory_respons | 0.86853677 |
| 110 | MP0002166_altered_tumor_susceptibility | 0.85703102 |
| 111 | MP0002933_joint_inflammation | 0.85052606 |
| 112 | MP0003111_abnormal_nucleus_morphology | 0.84826535 |
| 113 | MP0000703_abnormal_thymus_morphology | 0.84530756 |
| 114 | MP0000689_abnormal_spleen_morphology | 0.82242340 |
| 115 | MP0005058_abnormal_lysosome_morphology | 0.81629764 |
| 116 | MP0003183_abnormal_peptide_metabolism | 0.81084086 |
| 117 | MP0005666_abnormal_adipose_tissue | 0.80938430 |
| 118 | MP0008874_decreased_physiological_sensi | 0.80881807 |
| 119 | MP0000733_abnormal_muscle_development | 0.80772527 |
| 120 | MP0002084_abnormal_developmental_patter | 0.80738437 |
| 121 | MP0005464_abnormal_platelet_physiology | 0.80023591 |
| 122 | MP0003119_abnormal_digestive_system | 0.79040863 |
| 123 | MP0002254_reproductive_system_inflammat | 0.78952227 |
| 124 | MP0000767_abnormal_smooth_muscle | 0.78778305 |
| 125 | MP0001663_abnormal_digestive_system | 0.78673529 |
| 126 | MP0000467_abnormal_esophagus_morphology | 0.78276775 |
| 127 | MP0002088_abnormal_embryonic_growth/wei | 0.78044960 |
| 128 | MP0009785_altered_susceptibility_to | 0.77577267 |
| 129 | MP0003448_altered_tumor_morphology | 0.77366299 |
| 130 | MP0001873_stomach_inflammation | 0.77154100 |
| 131 | MP0010630_abnormal_cardiac_muscle | 0.77008846 |
| 132 | MP0002148_abnormal_hypersensitivity_rea | 0.76528136 |
| 133 | MP0002925_abnormal_cardiovascular_devel | 0.76384271 |
| 134 | MP0003984_embryonic_growth_retardation | 0.75797524 |
| 135 | MP0005023_abnormal_wound_healing | 0.75636797 |
| 136 | MP0002398_abnormal_bone_marrow | 0.74740183 |
| 137 | MP0002970_abnormal_white_adipose | 0.73544224 |
| 138 | MP0001672_abnormal_embryogenesis/_devel | 0.73289197 |
| 139 | MP0005380_embryogenesis_phenotype | 0.73289197 |
| 140 | MP0002269_muscular_atrophy | 0.73053502 |
| 141 | MP0000955_abnormal_spinal_cord | 0.72780535 |
| 142 | MP0005187_abnormal_penis_morphology | 0.72637199 |
| 143 | MP0000681_abnormal_thyroid_gland | 0.72329430 |
| 144 | MP0003633_abnormal_nervous_system | 0.72201519 |
| 145 | MP0000534_abnormal_ureter_morphology | 0.70403068 |
| 146 | MP0008872_abnormal_physiological_respon | 0.70114849 |
| 147 | MP0002722_abnormal_immune_system | 0.69553011 |
| 148 | MP0003763_abnormal_thymus_physiology | 0.68528209 |
| 149 | MP0000350_abnormal_cell_proliferation | 0.68413293 |
| 150 | MP0009745_abnormal_behavioral_response | 0.67751358 |
| 151 | MP0009703_decreased_birth_body | 0.67104251 |
| 152 | MP0002080_prenatal_lethality | 0.66830627 |
| 153 | MP0000579_abnormal_nail_morphology | 0.66036671 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hyperacusis (HP:0010780) | 3.87316545 |
| 2 | Abnormality of the lower motor neuron (HP:0002366) | 3.59276022 |
| 3 | Insomnia (HP:0100785) | 3.40166514 |
| 4 | Broad face (HP:0000283) | 3.37998429 |
| 5 | Cerebral aneurysm (HP:0004944) | 3.27696044 |
| 6 | Eczematoid dermatitis (HP:0000976) | 3.23809583 |
| 7 | Dysmetric saccades (HP:0000641) | 3.17735447 |
| 8 | Obstructive sleep apnea (HP:0002870) | 3.00302485 |
| 9 | Hemiplegia (HP:0002301) | 2.97059626 |
| 10 | Upper limb amyotrophy (HP:0009129) | 2.94667371 |
| 11 | Distal upper limb amyotrophy (HP:0007149) | 2.94667371 |
| 12 | Neoplasm of the heart (HP:0100544) | 2.86191894 |
| 13 | Distal lower limb amyotrophy (HP:0008944) | 2.85795820 |
| 14 | Hand muscle atrophy (HP:0009130) | 2.85011408 |
| 15 | Thin bony cortex (HP:0002753) | 2.79927867 |
| 16 | Elfin facies (HP:0004428) | 2.72461823 |
| 17 | Visual hallucinations (HP:0002367) | 2.72052924 |
| 18 | Macroorchidism (HP:0000053) | 2.64915627 |
| 19 | Renovascular hypertension (HP:0100817) | 2.61535685 |
| 20 | Pointed chin (HP:0000307) | 2.61318770 |
| 21 | Hemorrhage of the eye (HP:0011885) | 2.61094342 |
| 22 | Reticulocytosis (HP:0001923) | 2.59031767 |
| 23 | Colitis (HP:0002583) | 2.58046159 |
| 24 | Annular pancreas (HP:0001734) | 2.53314218 |
| 25 | Stridor (HP:0010307) | 2.50617999 |
| 26 | Cellulitis (HP:0100658) | 2.49411165 |
| 27 | Shallow orbits (HP:0000586) | 2.41784615 |
| 28 | Abnormality of the fingertips (HP:0001211) | 2.39577174 |
| 29 | Heterotopia (HP:0002282) | 2.38437002 |
| 30 | Turricephaly (HP:0000262) | 2.34751692 |
| 31 | Flat acetabular roof (HP:0003180) | 2.33947365 |
| 32 | Overriding aorta (HP:0002623) | 2.30149031 |
| 33 | Increased connective tissue (HP:0009025) | 2.28680657 |
| 34 | Gastrointestinal inflammation (HP:0004386) | 2.27483849 |
| 35 | Recurrent bacterial skin infections (HP:0005406) | 2.24227401 |
| 36 | Impaired smooth pursuit (HP:0007772) | 2.22300676 |
| 37 | Renal duplication (HP:0000075) | 2.21985715 |
| 38 | J-shaped sella turcica (HP:0002680) | 2.21714255 |
| 39 | Malnutrition (HP:0004395) | 2.18037697 |
| 40 | Recurrent abscess formation (HP:0002722) | 2.17655729 |
| 41 | Aneurysm (HP:0002617) | 2.13424301 |
| 42 | Achilles tendon contracture (HP:0001771) | 2.13238864 |
| 43 | Increased cerebral lipofuscin (HP:0011813) | 2.12734295 |
| 44 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.12411700 |
| 45 | Ependymoma (HP:0002888) | 2.09642279 |
| 46 | Abnormality of macrophages (HP:0004311) | 2.08968688 |
| 47 | Long toe (HP:0010511) | 2.08104744 |
| 48 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.07607258 |
| 49 | Pustule (HP:0200039) | 2.07372472 |
| 50 | Abnormality of the Achilles tendon (HP:0005109) | 2.07049091 |
| 51 | Action tremor (HP:0002345) | 2.06708592 |
| 52 | Easy fatigability (HP:0003388) | 2.05560027 |
| 53 | Ureteral stenosis (HP:0000071) | 2.01712858 |
| 54 | Ulnar bowing (HP:0003031) | 2.01190573 |
| 55 | Poikilocytosis (HP:0004447) | 2.01108156 |
| 56 | Gingivitis (HP:0000230) | 2.01085282 |
| 57 | Genetic anticipation (HP:0003743) | 2.00339812 |
| 58 | Supranuclear gaze palsy (HP:0000605) | 2.00102913 |
| 59 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.99693718 |
| 60 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.99359601 |
| 61 | Tetraplegia (HP:0002445) | 1.96742472 |
| 62 | Inflammation of the large intestine (HP:0002037) | 1.95980475 |
| 63 | Recurrent viral infections (HP:0004429) | 1.95901828 |
| 64 | Dysostosis multiplex (HP:0000943) | 1.95794566 |
| 65 | Abnormal social behavior (HP:0012433) | 1.95631317 |
| 66 | Impaired social interactions (HP:0000735) | 1.95631317 |
| 67 | Emphysema (HP:0002097) | 1.93821826 |
| 68 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 1.92758301 |
| 69 | Short 4th metacarpal (HP:0010044) | 1.92758301 |
| 70 | Chronic obstructive pulmonary disease (HP:0006510) | 1.92234401 |
| 71 | Obstructive lung disease (HP:0006536) | 1.92234401 |
| 72 | Hypertriglyceridemia (HP:0002155) | 1.91855656 |
| 73 | Narrow palate (HP:0000189) | 1.91643074 |
| 74 | Fragile skin (HP:0001030) | 1.90387257 |
| 75 | Gastrointestinal dysmotility (HP:0002579) | 1.89776459 |
| 76 | Pseudobulbar signs (HP:0002200) | 1.88401998 |
| 77 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.88190327 |
| 78 | Thoracic kyphosis (HP:0002942) | 1.87840761 |
| 79 | Increased IgE level (HP:0003212) | 1.87231529 |
| 80 | Mitral valve prolapse (HP:0001634) | 1.87117178 |
| 81 | Flat cornea (HP:0007720) | 1.87087491 |
| 82 | Focal seizures (HP:0007359) | 1.86481160 |
| 83 | Polycythemia (HP:0001901) | 1.84508234 |
| 84 | Aortic aneurysm (HP:0004942) | 1.84028652 |
| 85 | Seborrheic dermatitis (HP:0001051) | 1.83769775 |
| 86 | Amyotrophic lateral sclerosis (HP:0007354) | 1.83415963 |
| 87 | Ankyloglossia (HP:0010296) | 1.83291543 |
| 88 | Protrusio acetabuli (HP:0003179) | 1.83232176 |
| 89 | Status epilepticus (HP:0002133) | 1.82760725 |
| 90 | Bowel diverticulosis (HP:0005222) | 1.81486645 |
| 91 | Abnormality of the astrocytes (HP:0100707) | 1.81056075 |
| 92 | Astrocytoma (HP:0009592) | 1.81056075 |
| 93 | Ureteral obstruction (HP:0006000) | 1.79832713 |
| 94 | Broad palm (HP:0001169) | 1.79670370 |
| 95 | Trigonocephaly (HP:0000243) | 1.79481109 |
| 96 | Vertebral compression fractures (HP:0002953) | 1.79180235 |
| 97 | Urethral obstruction (HP:0000796) | 1.78927735 |
| 98 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.78281603 |
| 99 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.78229822 |
| 100 | Hypertensive crisis (HP:0100735) | 1.77786715 |
| 101 | Gastrointestinal infarctions (HP:0005244) | 1.77076460 |
| 102 | Increased serum ferritin (HP:0003281) | 1.76350855 |
| 103 | Sparse lateral eyebrow (HP:0005338) | 1.76177144 |
| 104 | Selective tooth agenesis (HP:0001592) | 1.75473276 |
| 105 | Autoimmune thrombocytopenia (HP:0001973) | 1.74990459 |
| 106 | Cervical subluxation (HP:0003308) | 1.74596823 |
| 107 | Asymmetry of the thorax (HP:0001555) | 1.74587388 |
| 108 | Mitral regurgitation (HP:0001653) | 1.74071165 |
| 109 | Abdominal distention (HP:0003270) | 1.73798107 |
| 110 | Distal lower limb muscle weakness (HP:0009053) | 1.73765563 |
| 111 | Dislocated radial head (HP:0003083) | 1.73658006 |
| 112 | Lymphangioma (HP:0100764) | 1.73462753 |
| 113 | Intention tremor (HP:0002080) | 1.73423995 |
| 114 | Vertebral arch anomaly (HP:0008438) | 1.72533310 |
| 115 | Myopathic facies (HP:0002058) | 1.72165190 |
| 116 | Rectal prolapse (HP:0002035) | 1.72029077 |
| 117 | Slow saccadic eye movements (HP:0000514) | 1.71791955 |
| 118 | Increased density of long bones (HP:0006392) | 1.70656360 |
| 119 | Postural instability (HP:0002172) | 1.70476066 |
| 120 | Disproportionate tall stature (HP:0001519) | 1.68938133 |
| 121 | Meningitis (HP:0001287) | 1.67762583 |
| 122 | Long palpebral fissure (HP:0000637) | 1.66149908 |
| 123 | Recurrent fungal infections (HP:0002841) | 1.66113260 |
| 124 | Increased nuchal translucency (HP:0010880) | 1.65508011 |
| 125 | Trismus (HP:0000211) | 1.65066964 |
| 126 | Broad distal phalanx of finger (HP:0009836) | 1.64832731 |
| 127 | Urinary urgency (HP:0000012) | 1.64458080 |
| 128 | Dilatation of the ascending aorta (HP:0005111) | 1.64324073 |
| 129 | Abnormality of the radial head (HP:0003995) | 1.64151952 |
| 130 | Abnormality of oral frenula (HP:0000190) | 1.64093901 |
| 131 | Germ cell neoplasia (HP:0100728) | 1.63990098 |
| 132 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.63338407 |
| 133 | Metaphyseal cupping (HP:0003021) | 1.63312320 |
| 134 | Premature skin wrinkling (HP:0100678) | 1.63122524 |
| 135 | Bladder diverticulum (HP:0000015) | 1.62691417 |
| 136 | Obsessive-compulsive behavior (HP:0000722) | 1.62359345 |
| 137 | Absent frontal sinuses (HP:0002688) | 1.61958821 |
| 138 | Axonal loss (HP:0003447) | 1.61405777 |
| 139 | Anal stenosis (HP:0002025) | 1.61059105 |
| 140 | Bone pain (HP:0002653) | 1.60911006 |
| 141 | Mucopolysacchariduria (HP:0008155) | 1.60113679 |
| 142 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.60113679 |
| 143 | Radial bowing (HP:0002986) | 1.59334673 |
| 144 | Premature rupture of membranes (HP:0001788) | 1.59299977 |
| 145 | Sacral dimple (HP:0000960) | 1.59211177 |
| 146 | Blue sclerae (HP:0000592) | 1.59157211 |
| 147 | Skin tags (HP:0010609) | 1.58782809 |
| 148 | Spinal cord lesions (HP:0100561) | 1.58770833 |
| 149 | Syringomyelia (HP:0003396) | 1.58770833 |
| 150 | Bowing of the arm (HP:0006488) | 1.58491661 |
| 151 | Bowed forearm bones (HP:0003956) | 1.58491661 |
| 152 | Truncus arteriosus (HP:0001660) | 1.58411518 |
| 153 | Viral hepatitis (HP:0006562) | 1.56338098 |
| 154 | Gastrointestinal stroma tumor (HP:0100723) | 1.56160427 |
| 155 | Short phalanx of the thumb (HP:0009660) | 1.55854485 |
| 156 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.55661600 |
| 157 | Milia (HP:0001056) | 1.55545049 |
| 158 | Diplopia (HP:0000651) | 1.55530001 |
| 159 | Abnormality of binocular vision (HP:0011514) | 1.55530001 |
| 160 | Dysdiadochokinesis (HP:0002075) | 1.53575723 |
| 161 | Depression (HP:0000716) | 1.52996498 |
| 162 | Ventricular fibrillation (HP:0001663) | 1.52383774 |
| 163 | Progressive cerebellar ataxia (HP:0002073) | 1.51753888 |
| 164 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.51184443 |
| 165 | Deep venous thrombosis (HP:0002625) | 1.51108695 |
| 166 | Long eyelashes (HP:0000527) | 1.50352870 |
| 167 | Fibroma (HP:0010614) | 1.50033224 |
| 168 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.49916559 |
| 169 | Ankle clonus (HP:0011448) | 1.49219874 |
| 170 | Broad metatarsal (HP:0001783) | 1.49074612 |
| 171 | Abnormality of the 4th metacarpal (HP:0010012) | 1.48794358 |
| 172 | Arnold-Chiari malformation (HP:0002308) | 1.48768865 |
| 173 | Lower limb amyotrophy (HP:0007210) | 1.48711675 |
| 174 | Myokymia (HP:0002411) | 1.48685140 |
| 175 | Abnormality of the thoracic spine (HP:0100711) | 1.48089417 |
| 176 | Hallux valgus (HP:0001822) | 1.47858055 |
| 177 | Polygenic inheritance (HP:0010982) | 1.47640683 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SMG1 | 3.71760782 |
| 2 | PRPF4B | 3.53458004 |
| 3 | TRIB3 | 3.49260190 |
| 4 | EEF2K | 3.44568992 |
| 5 | MAP3K10 | 3.37196492 |
| 6 | IRAK3 | 3.10617150 |
| 7 | ERN1 | 2.97000489 |
| 8 | CDK12 | 2.73402864 |
| 9 | PKN2 | 2.65803046 |
| 10 | TAOK1 | 2.55789185 |
| 11 | RIPK1 | 2.48397343 |
| 12 | MAP4K1 | 2.36710174 |
| 13 | ICK | 2.08805341 |
| 14 | MST1R | 1.94958210 |
| 15 | MAP3K9 | 1.91825546 |
| 16 | SIK1 | 1.89835286 |
| 17 | EPHA2 | 1.84538331 |
| 18 | SIK2 | 1.83233123 |
| 19 | PTK6 | 1.82344858 |
| 20 | NME2 | 1.72835840 |
| 21 | ALK | 1.72510416 |
| 22 | TYRO3 | 1.64474626 |
| 23 | PRKD3 | 1.63288604 |
| 24 | MAP3K7 | 1.60054240 |
| 25 | PDGFRA | 1.55556009 |
| 26 | CAMKK1 | 1.53760926 |
| 27 | PAK6 | 1.48212841 |
| 28 | IRAK4 | 1.44829335 |
| 29 | CAMK1G | 1.44829186 |
| 30 | BMX | 1.39039478 |
| 31 | DAPK2 | 1.37139548 |
| 32 | MTOR | 1.25575407 |
| 33 | GRK6 | 1.22882160 |
| 34 | MARK2 | 1.21085658 |
| 35 | STK38 | 1.20976923 |
| 36 | MAP3K3 | 1.20822977 |
| 37 | KSR2 | 1.19964949 |
| 38 | TTN | 1.18129755 |
| 39 | STK10 | 1.16768408 |
| 40 | PRKCH | 1.09169022 |
| 41 | CAMK1D | 1.02995561 |
| 42 | MAP3K14 | 1.02836231 |
| 43 | CDC42BPA | 1.01779276 |
| 44 | NTRK2 | 1.01666794 |
| 45 | IRAK2 | 1.01609990 |
| 46 | LRRK2 | 1.00750654 |
| 47 | PTK2 | 1.00488956 |
| 48 | FGFR4 | 1.00305275 |
| 49 | MAP3K13 | 0.92582819 |
| 50 | TBK1 | 0.91349241 |
| 51 | LATS2 | 0.91320150 |
| 52 | EPHB1 | 0.87520533 |
| 53 | NEK2 | 0.87247526 |
| 54 | RPS6KC1 | 0.86900350 |
| 55 | RPS6KL1 | 0.86900350 |
| 56 | RET | 0.84623443 |
| 57 | DDR2 | 0.83653811 |
| 58 | PRKD2 | 0.83460065 |
| 59 | FGFR1 | 0.80743799 |
| 60 | BTK | 0.76875888 |
| 61 | SCYL2 | 0.76628545 |
| 62 | BRD4 | 0.74975672 |
| 63 | STK11 | 0.74210765 |
| 64 | PAK2 | 0.73627122 |
| 65 | NTRK3 | 0.73319644 |
| 66 | BLK | 0.73257510 |
| 67 | LMTK2 | 0.72119266 |
| 68 | MAP3K11 | 0.70652936 |
| 69 | TNK2 | 0.70214520 |
| 70 | KDR | 0.69028372 |
| 71 | NTRK1 | 0.68646962 |
| 72 | SIK3 | 0.67257584 |
| 73 | RPS6KA6 | 0.66682997 |
| 74 | MAP2K2 | 0.66261998 |
| 75 | PDGFRB | 0.66036850 |
| 76 | RPS6KB2 | 0.64742511 |
| 77 | FGFR2 | 0.63814280 |
| 78 | CDK6 | 0.63133106 |
| 79 | PRKG2 | 0.61853310 |
| 80 | JAK1 | 0.61770819 |
| 81 | MAP3K8 | 0.61227514 |
| 82 | RPS6KA2 | 0.60925801 |
| 83 | CAMK4 | 0.60640703 |
| 84 | CDK4 | 0.60356612 |
| 85 | JAK2 | 0.60087771 |
| 86 | HIPK2 | 0.59966049 |
| 87 | FGFR3 | 0.59907160 |
| 88 | SGK3 | 0.59375218 |
| 89 | DYRK1B | 0.59057264 |
| 90 | PAK4 | 0.58954935 |
| 91 | AKT3 | 0.57260301 |
| 92 | DMPK | 0.56955973 |
| 93 | PDK1 | 0.56904688 |
| 94 | MAP3K1 | 0.56876806 |
| 95 | MINK1 | 0.56284267 |
| 96 | TYK2 | 0.55849453 |
| 97 | TESK2 | 0.55550694 |
| 98 | DAPK1 | 0.54539173 |
| 99 | CDK7 | 0.54169849 |
| 100 | MAPK12 | 0.54012663 |
| 101 | MAP2K3 | 0.52723978 |
| 102 | MAP3K6 | 0.52677848 |
| 103 | MAPK11 | 0.52376735 |
| 104 | TAOK3 | 0.51466060 |
| 105 | MAP3K2 | 0.50847452 |
| 106 | HCK | 0.50576514 |
| 107 | ZAP70 | 0.47053989 |
| 108 | MET | 0.46973571 |
| 109 | JAK3 | 0.46830541 |
| 110 | TAOK2 | 0.45478282 |
| 111 | RPS6KA1 | 0.45276193 |
| 112 | ILK | 0.45004265 |
| 113 | TESK1 | 0.44543896 |
| 114 | MAP2K6 | 0.43719100 |
| 115 | PRKD1 | 0.43656561 |
| 116 | PRKCI | 0.43652255 |
| 117 | CHUK | 0.43470776 |
| 118 | RIPK4 | 0.42767833 |
| 119 | CDK5 | 0.42544111 |
| 120 | CAMK1 | 0.42541365 |
| 121 | PDPK1 | 0.41701381 |
| 122 | FYN | 0.41697072 |
| 123 | ITK | 0.41358795 |
| 124 | IRAK1 | 0.40722689 |
| 125 | KSR1 | 0.40600927 |
| 126 | ERBB2 | 0.39998726 |
| 127 | MELK | 0.39929254 |
| 128 | MAPKAPK2 | 0.39905214 |
| 129 | CSF1R | 0.39492997 |
| 130 | UHMK1 | 0.38828256 |
| 131 | IKBKE | 0.38175542 |
| 132 | IKBKB | 0.37910116 |
| 133 | RPS6KA3 | 0.37844487 |
| 134 | CSK | 0.36376069 |
| 135 | MAPK8 | 0.36121713 |
| 136 | FES | 0.35753769 |
| 137 | NEK1 | 0.35612520 |
| 138 | CDK9 | 0.35441795 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.85034816 |
| 2 | Other glycan degradation_Homo sapiens_hsa00511 | 2.73169313 |
| 3 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.73684175 |
| 4 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.71853075 |
| 5 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.71157105 |
| 6 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.61598680 |
| 7 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.59212598 |
| 8 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.58978589 |
| 9 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.58148336 |
| 10 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.54167161 |
| 11 | Lysine degradation_Homo sapiens_hsa00310 | 1.50343756 |
| 12 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.46915968 |
| 13 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.46218481 |
| 14 | Leishmaniasis_Homo sapiens_hsa05140 | 1.42783499 |
| 15 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.37497783 |
| 16 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.36096652 |
| 17 | Long-term potentiation_Homo sapiens_hsa04720 | 1.32376635 |
| 18 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.31642045 |
| 19 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.30259967 |
| 20 | Sulfur relay system_Homo sapiens_hsa04122 | 1.29003721 |
| 21 | Bile secretion_Homo sapiens_hsa04976 | 1.27565711 |
| 22 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.26328375 |
| 23 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.25894132 |
| 24 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.24441568 |
| 25 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.22641561 |
| 26 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.20231209 |
| 27 | Hepatitis C_Homo sapiens_hsa05160 | 1.20225510 |
| 28 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.17818213 |
| 29 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.15971868 |
| 30 | Hepatitis B_Homo sapiens_hsa05161 | 1.15663596 |
| 31 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.15480784 |
| 32 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.14763043 |
| 33 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.13594085 |
| 34 | Salivary secretion_Homo sapiens_hsa04970 | 1.13508976 |
| 35 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.13471059 |
| 36 | Influenza A_Homo sapiens_hsa05164 | 1.12914711 |
| 37 | Glioma_Homo sapiens_hsa05214 | 1.12314788 |
| 38 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.11672717 |
| 39 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.11449208 |
| 40 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.10127980 |
| 41 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.10022412 |
| 42 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.06608206 |
| 43 | Apoptosis_Homo sapiens_hsa04210 | 1.04708980 |
| 44 | Thyroid cancer_Homo sapiens_hsa05216 | 1.04216533 |
| 45 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.03997176 |
| 46 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.03994658 |
| 47 | Insulin resistance_Homo sapiens_hsa04931 | 1.03882820 |
| 48 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.03286756 |
| 49 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.03194342 |
| 50 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.03061208 |
| 51 | Circadian entrainment_Homo sapiens_hsa04713 | 0.99490471 |
| 52 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.99064261 |
| 53 | Galactose metabolism_Homo sapiens_hsa00052 | 0.98865753 |
| 54 | Measles_Homo sapiens_hsa05162 | 0.98314382 |
| 55 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.97623924 |
| 56 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.96818468 |
| 57 | HTLV-I infection_Homo sapiens_hsa05166 | 0.96310613 |
| 58 | Tuberculosis_Homo sapiens_hsa05152 | 0.94239172 |
| 59 | Prion diseases_Homo sapiens_hsa05020 | 0.93272694 |
| 60 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.91413670 |
| 61 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.91354207 |
| 62 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.91167150 |
| 63 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.90844231 |
| 64 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.90595256 |
| 65 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.90416657 |
| 66 | Insulin secretion_Homo sapiens_hsa04911 | 0.89084449 |
| 67 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.89068158 |
| 68 | GABAergic synapse_Homo sapiens_hsa04727 | 0.87473436 |
| 69 | Endometrial cancer_Homo sapiens_hsa05213 | 0.87293743 |
| 70 | Olfactory transduction_Homo sapiens_hsa04740 | 0.87215062 |
| 71 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.86709508 |
| 72 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.86541790 |
| 73 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.86181417 |
| 74 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.85960459 |
| 75 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.85022007 |
| 76 | Prostate cancer_Homo sapiens_hsa05215 | 0.84672733 |
| 77 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.83507471 |
| 78 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.83492473 |
| 79 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.81199863 |
| 80 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.78637993 |
| 81 | Endocytosis_Homo sapiens_hsa04144 | 0.78278210 |
| 82 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.78256443 |
| 83 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.77985849 |
| 84 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.76121894 |
| 85 | Viral myocarditis_Homo sapiens_hsa05416 | 0.75926114 |
| 86 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.74778474 |
| 87 | Long-term depression_Homo sapiens_hsa04730 | 0.74739425 |
| 88 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.74521636 |
| 89 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.74321074 |
| 90 | Platelet activation_Homo sapiens_hsa04611 | 0.74237061 |
| 91 | Gap junction_Homo sapiens_hsa04540 | 0.73547561 |
| 92 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.72608808 |
| 93 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.72466274 |
| 94 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.71978056 |
| 95 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.71552479 |
| 96 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.71439336 |
| 97 | Allograft rejection_Homo sapiens_hsa05330 | 0.71237327 |
| 98 | Morphine addiction_Homo sapiens_hsa05032 | 0.71206776 |
| 99 | Shigellosis_Homo sapiens_hsa05131 | 0.71015661 |
| 100 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.69968381 |
| 101 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.69843039 |
| 102 | ABC transporters_Homo sapiens_hsa02010 | 0.68552991 |
| 103 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.68139092 |
| 104 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.67232424 |
| 105 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.67230293 |
| 106 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.67033035 |
| 107 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.66200382 |
| 108 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.65521795 |
| 109 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.64646421 |
| 110 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.64581067 |
| 111 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.64331928 |
| 112 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.64006819 |
| 113 | Renin secretion_Homo sapiens_hsa04924 | 0.63931027 |
| 114 | Bladder cancer_Homo sapiens_hsa05219 | 0.63680972 |
| 115 | Colorectal cancer_Homo sapiens_hsa05210 | 0.63359755 |
| 116 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.62881299 |
| 117 | Salmonella infection_Homo sapiens_hsa05132 | 0.62181295 |
| 118 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.61825980 |
| 119 | Cocaine addiction_Homo sapiens_hsa05030 | 0.61780942 |
| 120 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.61758664 |
| 121 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.61499917 |
| 122 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.60952129 |
| 123 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.60708992 |
| 124 | Lysosome_Homo sapiens_hsa04142 | 0.60450962 |
| 125 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.59918549 |
| 126 | Nicotine addiction_Homo sapiens_hsa05033 | 0.59380942 |
| 127 | Adherens junction_Homo sapiens_hsa04520 | 0.58860255 |
| 128 | Malaria_Homo sapiens_hsa05144 | 0.58525538 |
| 129 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.57493452 |
| 130 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.57348387 |
| 131 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.57332758 |
| 132 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.57071087 |
| 133 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.56517740 |
| 134 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.56502165 |
| 135 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.56481069 |
| 136 | Pertussis_Homo sapiens_hsa05133 | 0.56128551 |
| 137 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.55939862 |
| 138 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.55936282 |
| 139 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.54772157 |
| 140 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.54270340 |
| 141 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.53671845 |
| 142 | Focal adhesion_Homo sapiens_hsa04510 | 0.53418644 |
| 143 | Amoebiasis_Homo sapiens_hsa05146 | 0.52308744 |
| 144 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.52304479 |
| 145 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.50643924 |
| 146 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.50124413 |
| 147 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.49730662 |

